This study assed whether exposure of male rats to two cstrogenic, environmental chemicals, 4-octyiphenol (OP) and butyl bezyl p (BBP) 
and skepticism (3) . The most recent data from a number of countries, which have charted changes in sperm counts in semen donors over the past 20-25 years, have, however, all reported a marked and significant downward trend (4) (5) (6) . The most comprehensive of these studies, in Paris, concluded that sperm counts in fertile men have declined by around 2% per year over the past 23 years (6) . Moreover, two of the cited studies (5, 6) identified that the temporal decline in sperm counts appears to apply to men born from around 1950 onwards.
Two years ago, we hypothesized (7) that the reported decline in sperm counts might be related to an increasing incidence of other disorders of development of the male reproductive system (e.g., testicular cancer) and that this could have arisen because of increased exposure of the developing fetus to estrogens. One potential source of this increased estrogen exposure was via environmental estrogenic chemicals, or "xenoestrogens," the release of which has more or less coincided with the decline in sperm counts (8, 9) . Concern about such hormonally active pollutants, such as chlorinated pesticides, has been voiced for [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] years (10) , but has become more acute recently because of the discovery of a range of new xenoestrogens, including bisphenol-A (11) , certain alkylphenolic chemicals (12) (13) (14) , certain phthalates (15) , as well as a number of pesticides (16) . Most of these estrogenic chemicals are ubiquitous in the environment, and humans are exposed to them daily by a number of routes (9) . However, the risk to humans from these chemicals is currently theoretical because there are no data to show that these chemicals can cause any disorder of reproductive development or function in animals.
Pathways via which exposure of the developing male fetus or neonate to estrogenic chemicals could result in reduced testicular size and sperm production in adult life have been identified (2, 7, 9) , but there is no direct evidence to confirm whether this hypothesis has any factual basis. It is known that some phthalates are passed from the mother both across the placenta (17) and via milk (18) , although comparable data on the transfer of alkylphenolic chemicals are lacking. The aim of the present studies was to evaluate whether exposure of the male rat fetus/neonate to either of two environmental estrogenic chemicals has any effect on testicular size and spermatogenesis in adult life.
Material and Methods
Animals and treatments. All rats used in these studies were of the Wistar strain and were bred in our own animal facility. They were maintained under standard, controlled conditions and had free access to food and water. Administration of chemicals was via the drinking water, which was provided in a bottle per cage. A stock solution of each dose of chemicals was made by dissolving a weighed amount in ethanol such that addition of 0.5 ml of this stock to 5 1 of tapwater resulted in the test dose; control animals had 0.5 ml ethanol/5 added to their drinking water.
Study design. The most likely mechanism via which estrogenic chemicals could cause an irreversible reduction in testicular size and sperm production is by decreasing the number of Sertoli cells. In adult life, the number of Sertoli cells determines testicular size and sperm production in all animals that have been studied (19) . In the male rat, Sertoli cells begin to proliferate soon after testicular differentiation (about day 1 5 of gestation) and continue until around day 15 of postnatal life, with perhaps minor proliferation until around day 21; after this time, no further Sertoli cell proliferation can occur (19) . Thus, by day 22, the ultimate size to which the testis will grow in adulthood (90-95 days of age) has been predetermined (19L22).
Our studies were designed such that animals were exposed to chemicals for Articles * Estrogenic chemicals and testis development either the postnatal period (i.e., days 1-22 after birth) of Sertoli cell proliferation (study 1; see Fig. 1 ) or for the complete period of Sertoli cell proliferation (studies 2 and 3; see Fig. 1 ). In the latter two studies, treatments were administered to adult female rats for 2 weeks before mating with a sexually experienced male, throughout mating, throughout gestation, and up until day 22 after giving birth (Fig. 1) . This protocol of exposure was used to assess the possible effects of bioaccumulation. In all three studies, exposure of the male offspring to the test chemicals was thus largely indirect, via the placenta or milk.
In study 1, in which there was no prenatal exposure to the test chemicals, litters were culled to eight pups on the day of birth (day 1) by culling excess females. The same was done in study 2. In study 3 , the full litter size was maintained from birth through day 22. The female offspring of test litters were not evaluated. Adult females used for mating in studies 2 and 3 were the same: when offspring of these females were weaned at the completion of study 2, the mothers were maintained on the same treatment for 2 weeks, then mated and exposed until the weaning of study 3 offspring (Fig. 1) .
Test chemicals and doses. Three chemicals were selected for study based on the results of in vitro investigations suggesting that they were estrogenic (13) (14) (15) . Of the three, 4-tert-octylphenol (OP; Aldrich Chemical Co., Gillingham, UK) and butyl benzyl phthalate (BBP; Chem Service, West Chester, Pennsylvania) were both estrogenic in vitro, whereas an octylphenol polyethoxylate withl a side-chain of five ethoxylate groups (OPP; Igepal C Aldrich) was essentially devoid c genicity in vitro. In study 1, nonylp carboxylic acid (NPIEC, K & Cleveland, Ohio), which is appro. 10-fold less estrogenic in vitro t r (14) , was also assessed at a sing Diethylstilbestrol (DES; Sigma C Co., Poole, Dorset, UK), which is nonsteroidal estrogen, was incluc positive control.
Little is known about the d4 exposure of humans to the chemic in the present studies, but concer of alkylphenolic compounds in the environment reportedly range up dreds of micrograms per milliliter whereas human intake of phtho reportedly as high as 15 mg I (200-300 pg/kg/day) (25) . There chose doses that would be mildl genic based on in vitro analyses but which remained within an c magnitude of the possible e] mental/human intake level. We te at 1000 and 100 pg/l in all three (and also at 10 pg/l in study 1) , OPP and BBP were tested only at gle dose of 1000 pg/l in studies 2 DES was tested at 100 and 10 pg/l 1 and at 100 pg/l in studies 2 described elsewhere (26) . The fixed testes in study were then cut transversely with a razor d 3. No blade into 2-mm-thick sections and then hemicals into small blocks (1-2 mm2). After postfix-:hed the ation for 12-16 hr in the same fixative, the nts, was blocks were processed and embedded in mply to plastic as described previously (26) . Semiemicals thin sections (0.5 pm) were then cut, lowever, stained with toluidine blue, and examined al intake using a Zeiss photomicroscope.
some of To provide a preliminary quantitative y weighassessment of spermatogenesis, seminiferous tubules at stages VII-VIII of the spermatogenic cycle were subjected to image analysis (Cue-2, Olympus) to determine the cross-sectional area of the seminiferous Fi tubule and seminiferous epithelium (27. We analyzed 10 round cross-sections for two or three rats per treatment group and calculated the mean and standard deviation for each animal. Stages VII-VIII were chosen for analysis because they contain representative germ cells from all steps of development (19) . Daily sperm production. In some of the animals from study 3, daily sperm production was determined by counting homogenization-resistant spermatids, using minor modifications of the techniques of Johnson et al. (28, 29 
Results
Litter size and composition at birth were not evaluated in study 1, as there was no prenatal treatment of the mothers. In studies 2 and 3, in which the mothers were treated prenatally, there was no effect of treatment with OP, OPP, or BBP, on litter size or composition. Exposure to DES (100 jig/l) reduced average litter size by nearly half in study 3 and had a more minor effect in study 2 (Table 1) . Curiously, the proportion of male offspring was increased significantly in the DES-exposed group in study 3 (Table 1) .
At weaning, which corresponded to the cessation of treatment in all three studies, body weight of DES-exposed offspring was reduced significantly in studies 1 and 2 but was increased significantly in study 3, perhaps because of the much smaller lirter sizes (Table 1) . Otherwise, exposure to any of the test chemicals had either no effect or, more commonly, resulted in a significant increase in body weight on day 22 (Table 1) .
In study 1, mean body weight was generally higher in treatment groups, compared with controls, but only in the case of OP (100 pg/I) did this reach statistical significance (Table 2 ). Average testis weight was reduced marginally, but significantly, in animals exposed to DES (100 pg/l) and OP (1000 pg/l), and relative testis weight (i.e., relative to body weight or to kidney weight) was reduced significantly in these two groups and in animals exposed to the intermediate concentration (100 pg/l) of OP ( Table 2 ). Kidney weight was increased markedly in animals exposed to the two highest doses of OP and, although this may have been due to some extent to the greater average body weight of the animals, a significant difference in kidney weight relative to body weight was still evident (Table 2) .
In study 2, mean body weight in animals exposed to DES or OPP was reduced when compared to controls, whereas animals exposed to either dose of OP were increased in size by 8% or more (Table 3) . Except for animals exposed to the lower dose of OP (100 pg/I), all other treatment groups exhibited a highly significant decrease in absolute testis weight and in the ratio of testis/kidney size (Table 3) ; all treatment groups showed a significant decrease in relative testis weight. There were some minor, but significant, changes in absolute and relative kidney weight in some of the treatment groups. Ventral prostate weight was reduced by 16% in DES-treated animals, though this effect largely disappeared when the size relative to body weight was evaluated (Table 3) . bLitter size, etc., also affected by treatment (see Table 1 ).
*p<0.05, **p<0.01, tp<0.001 compared to respective control value.
Relative weight of the prostate was reduced significantly in animals exposed to either dose of OP. In study 3, animals were noticeably smaller on average, both at weaning and at 90-95 days of age, than animals in studies 1 and 2 (Table 4) . Under this regimen, no treatment group in adult life had a larger mean body weight than the control group, and two of the groups (OP at 100 pg/l and OPP) showed a small but significant decrease in body weight relative to controls. In all treatment groups, testis weight was reduced significantly when compared to controls, though when expressed relative to body weight this difference disappeared for the groups exposed to DES or the lower dose of OP (Table 4) . Kidney weight was reduced noticeably in animals exposed to 1000 pg OP/I, a difference still evident when expressed relative to body weight; however, the testis/kidney weight ratio in this group was still significantly lower than that observed in the control group (Table  4) . As in study 2, ventral prostate weight was reduced significantly in DES-exposed animals but, in study 3, a significant reduction was also obvious in animals exposed to OP, particularly at the higher dose (Table   4) .
Although exposure to the test chemicals throughout gestation and neonatal life resulted in fairly consistent reductions in testis size as adults, these decreases were only on the order of 5-13%. However, plotting the data for testis weight against body weight for four of the treatment groups from studies 2 and 3 (i.e., DES, OP at 1000 pg/l, BBP) shows that the treated animals have a different distribution from controls (Fig. 2) . This is most evident by noting how few of the values for treated animals lie above the linear regression line plotted for the control group. Although a similar trend was evident in the DESexposed animals, testicular weights were far more variable in this treatment group, probably because of the confounding effects of this treatment on litter size, etc.
Testicular morphology was indistinguishable in animals from the control and treatment groups, and no obvious abnormalities in the seminiferous tubules, interstitium, or vasculature were evident (Fig.  3) . Image analysis confirmed this impression by demonstrating no adverse effect of treatment on the cross-sectional parameters of stage VII-VIII seminiferous tubules; indeed, for the most part, these parameters tended to be higher for the treated animals than for the controls, though this is based on a small sample size (Table 5) .
Daily sperm production in control animals from study 3 averaged 24.9 ± 3.6 x 106 per testis per day (mean ± SD, n = 12), which agrees closely with that determined morphometrically by Wing and Christensen (32) . Animals exposed during fetal and neonatal life to DES, OP (1000 pg/I), or BBP in study 3 all showed significant reductions of 10-21% in the mean daily sperm production (Fig. 4) , which were proportionately similar to the decrease in testis weight (Table 4) ; tissue from animals exposed to OPP was not evaluated.
The nominal intake of chemical was assessed in study 3 for animals in two of the treatment groups (OP at 1000 pg/l, BBP) based on water intake, and ranged from around 125 pg/kg/day in the first 2 days after birth to 370 pg/kg/day just before weaning ( Table 6 ). As these calculations take no account of spillage, adsorption, or degradation of the chemicals (which were not evaluated), these values for intake can be viewed as overestimates of the actual intake. The level of water intake was not affected by treatment (Table 6 ).
Discussion
The purpose of the present studies was to assess whether exposure of male rats to known estrogenic, environmental chemicals during gestation or neonatal life had any adverse effect on testicular size and spermatogenesis when these animals (33) , and a recent study in trout (34) has demonstrated inhibition of testis growth in vivo after exposure to estrogenic alkylphenolic chemicals. Ultimate testicular size in all mammals that have been investigated is determined by the number of Sertoli cells present in the testis, despite the fact that it is the germ cells, rather than the Sertoli cells, which constitute the bulk of the testis (19, 21) . Each Sertoli cell can only support a fixed number of germ cells through their development into spermatozoa, and hence the more Sertoli cells present, the more germ cells present, and thus the larger the testis. The number of Sertoli cells can be increased or decreased experimentally in various animals by a number of treatments, with corresponding changes in testicular size and daily sperm production, and the same relationship appears to apply to men (1) (2) (3) (4) (5) (6) (7) (8) (9) . Usually, when Sertoli cell number is altered, there is little change in the crosssectional appearance or size of the seminiferous tubules because Sertoli cell number affects primarily the length, not the breadth, of the tubules (20, 21) . The number of Sertoli cells per testis is determined by the rate and duration of their proliferation, which usually occurs during a precisely timed period that begins in fetal life (shortly after testicular differentiation) and continues into neonatal life for a period that varies according to the species (19) .
In the present studies, rats were exposed to estrogenic chemicals for either part (study 1) or all (studies 2 and 3) of the period when Sertoli cell proliferation occurs (Fig. 1 ). If these treatments had reduced the rate of Sertoli cell proliferation, we would expect that, in adult life, the testes would be smaller and daily sperm production will be reduced, but the crosssectional appearance of the seminiferous tubules would probably be unchanged. Our findings are consistent with the treatments having reduced Sertoli cell number, though morphometric determination of Sertoli cell number will be necessary to determine whether this interpretation is correct; as the expected change in Sertoli cell number would only be of the order of 2-4%, measurements in large cohorts of animals will be necessary to demonstrate this. However, an earlier study (35) demonstrated that exposure of rats to di(2-ethylhexyl)phthalate for 5 days during neonatal life resulted in a reduction in Sertoli cell number and some reduction in testis size and sperm production in adulthood; however, the level of phthalate exposure in this study was at least 1000-fold higher than in the present studies. When animals are exposed to test chemicals, it is possible that toxic effects on organs (e.g., the liver) other than the testis or reproductive axis could lead to a reduction in testicular size and thus daily sperm production as a result of nonspecific effects. Although this possibility cannot be excluded completely, the present data on body weight and kidney weight provide little evidence for any such effect-indeed, in most instances treated animals were larger than the controls. The exception was animals exposed to DES (positive controls), which showed consistent evidence of some- what lower body weights. The explanation for this effect is not clear from the present studies, but it is likely that lactation may have been impaired by DES (36) . If this is the case, it is somewhat puzzling why there was no evidence for such effects in animals exposed to any of the estrogenic chemicals, as these caused equal, or even larger, reductions in testicular weight than did DES exposure. This discrepancy could reflect differences in the pharmacokinetics of the chemicals compared with DES.
Although the estrogenic chemicals tested in the present studies exerted similar effects on testis size and daily sperm production, no evidence is provided that these effects resulted specifically from the estrogenicity of these compounds. The fact that treatment with OPP caused a similar reduction in testicular size as did treatment with OP, despite the fact that OP is nonestrogenic in vitro (14) , could be interpreted as evidence against estrogenicity per se being a common causal mechanism. However, it is possible that, when ingested, OPP is metabolized such that the five ethoxylate groups are cleaved, resulting in the formation of OP. This interpretation is supported by the observation that, whereas short-chain alkylphenol polyethoxylates (such as OPP) do not bind to the estrogen receptor in cell-free systems (14) , they are estrogenic in cell-based in vitro assays (13, 14) and in vivo (34) . It will be important in future studies to establish unequivocally whether only estrogenic chemicals are able to reduce testicular size and daily sperm production in the manner described here.
Irrespective of whether the reduction in testis size and daily sperm production caused by developmental exposure to OP or BBP resulted from their estrogenicity, the key question is whether these effects have relevance to humans. This is a complex issue which requires detailed dose-response data and measurement of the actual levels of the administered chemicals in the male rats. It would be appropriate to consider whether the nominal level of exposure of rats to OP and BBP in the present studies (which is presumed to be an overestimate of actual exposure levels) bears any relationship to the equivalent level of human exposure. There are little or no data specifically for OP, but there is some information on the environmental levels of the class of compounds to which OP belongs, namely, alkylphenol polyethoxylates, several of which have been shown to be estrogenic (14) . Reported levels of these compounds in river water vary from the low micrograms per liter (37) to tens and hundreds of micrograms per liter (23, 24) , which approach the nominal levels of exposure in the present study. Even tapwater has been reported to contain estrogenic degradation products of both nonylphenol ethoxylate and octylphenol ethoxylate (38) woman would lead to an intake of approximately 40 pg/kg/day, which approaches the nominal intake values in the present study.
As the levels of total phthalates in other dairy produce can exceed 50 mg/kg (42, 43) , and there are many other possible sources of human exposure to these compounds, the present findings suggest that further studies of the estrogenicity of phthalates should be a priority. There is already a huge literature on the toxicity of phthalates, including their testicular toxicity, but few of the published studies have been able to detect developmental effects similar to those reported here. This is borne out by the reported no-observed effect level (NOEL) of BBP for testicular toxicity in rats of 125-150 mg/kg/day (44, 45) . The fact that, in the present studies, nominal intake of 300-fold lower amounts than the NOEL resulted in around a 10% decrease in testicular weight in two separate studies with a commensurate fall in daily sperm production, argues further that the cause of these decreases differs from the previously reported toxic effects of these compounds on the testis. The present data do not provide direct evidence of a link between human exposure to environmental estrogens and falling sperm counts in men. However, the findings do provide some preliminary, indirect evidence that exposure of rats to certain environmental estrogenic chemicals during gestation or neonatal life can result in reduced testicular size and sperm production in adulthood. As these effects occurred in rats after only 3-9 weeks of exposure, whereas in men the corresponding window of development (and Sertoli cell proliferation) spans several years, there is at least the theoretical possibility that similar effects in men might be of larger magnitude than those described here for the rat. However, considerably more work, particularly in establishing the likely level of human exposure to estrogenic chemicals, will be necessary if the risk to man from such exposure is to be assessed with any accuracy.
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